Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02218138 · ClinicalTrials.gov registry record · NA

Learning to BREATHE: A Randomized Controlled Trial to Lower Diabetes Risk in Adolescent Girls

A NA study, sponsored by Colorado State University.

Completed
Registry status
NA
Development phase
35
Enrollment target

NCT02218138 is a NA study that has completed, run by Colorado State University. The registered enrollment target is 35 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02218138, a NA study, has completed, sponsored by Colorado State University.

COMPLETED
Registry status
NA
Development phase
35 participants
Enrollment target

Study Summary

Type 2 diabetes is a chronic disease that puts people at risk for major health problems like heart disease. Type 2 diabetes is the most common type of diabetes in adults. However, there has been a concerning rise in type 2 diabetes among teenagers. Diabetes develops through poor insulin sensitivity, meaning that insulin - an important chemical the body makes to keep blood sugar normal - isn't working properly. Type 2 diabetes can be prevented by improving insulin sensitivity. Stress is related to insulin sensitivity. Individuals who feel stressed have worse insulin sensitivity than individuals who do not feel stressed. In adults, decreasing stress leads to improvements in insulin sensitivity, but this hasn't been tested in teenagers. The purpose of this study is to find out if taking part in a brief group program to decrease stress will improve insulin sensitivity and lower diabetes risk in teenage girls.

Interventions

  • BEHAVIORAL Learning 2 BREATHE
  • BEHAVIORAL Colorado Blues

Trial Details

FieldValue
Enrollment Target 35 participants
Start Date 2013-01
Est. Completion 2016-08
Phase NA

Sponsor

Colorado State University

94 total trials

What the Registry Record Tells You About NCT02218138

The ClinicalTrials.gov registry entry for NCT02218138 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Colorado State University, which has 94 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Learning 2 BREATHE is the first listed.

NCT02218138 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02218138 about?

NCT02218138 is a clinical study titled "Learning to BREATHE: A Randomized Controlled Trial to Lower Diabetes Risk in Adolescent Girls". Type 2 diabetes is a chronic disease that puts people at risk for major health problems like heart disease. Type 2 diabetes is the most common type of diabetes in adults. However, there has been a concerning rise in type 2 diabetes among teenagers. Diabetes develops through poor insulin sensitivity,...

What is the current status of trial NCT02218138?

This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2013-01. Estimated completion is 2016-08.

What interventions are being tested in trial NCT02218138?

The interventions under investigation include: Learning 2 BREATHE (BEHAVIORAL), Colorado Blues (BEHAVIORAL).

Who is sponsoring clinical trial NCT02218138?

This trial is sponsored by Colorado State University, which has 94 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.